NR 507 ADVANCED PATHOPHYSIOLOGY PRACTICE QUESTIONS & ANSWERS BUNDLE | LATEST 2025–2026 EXAM PREP | COMPREHENSIVE STUDY GUIDE WITH VERIFIED RATIONALES | WEEK-BY-WEEK REVIEW | GUARANTEED SUCCESS RESOURCE

NR 507 ADVANCED PATHOPHYSIOLOGY PRACTICE QUESTIONS &
ANSWERS BUNDLE | LATEST 2025–2026 EXAM PREP |
COMPREHENSIVE STUDY GUIDE WITH VERIFIED RATIONALES | WEEK-
BY-WEEK REVIEW | GUARANTEED SUCCESS RESOURCE
WHICH BEST DESCRIBES A TYPE 1 HYPERSENSITIVITY REACTION?

A. IGG-MEDIATED CYTOTOXIC REACTION

B. IMMUNE COMPLEX DEPOSITION IN TISSUES

C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION

D. DELAYED T-CELL-MEDIATED RESPONSE

CORRECT ANS: C. IGE-MEDIATED IMMEDIATE ALLERGIC REACTION


FEEDBACK: TYPE 1 HYPERSENSITIVITY REACTIONS OCCUR WITHIN MINUTES AND
INVOLVE IGE ANTIBODIES AND MAST CELL DEGRANULATION




SELECT ALL THAT APPLY:



WHICH FINDINGS ARE CONSISTENT WITH ANAPHYLAXIS?

A. HYPOTENSION

B. BRONCHOCONSTRICTION

C. BRADYCARDIA

D. URTICARIA

E. INCREASED MUCUS PRODUCTION

CORRECT ANS: A. HYPOTENSION
B. BRONCHOCONSTRICTION

D. URTICARIA

, E. INCREASED MUCUS PRODUCTION



FEEDBACK: ANAPHYLAXIS CAUSES VASODILATION, BRONCHOCONSTRICTION, HIVES,
AND INCREASED MUCUS PRODUCTION.




SELECT ALL THAT APPLY:



WHICH DISEASES ARE ASSOCIATED WITH TYPE 2 HYPERSENSITIVITY?

A. MYASTHENIA GRAVIS

B. SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)

C. HEMOLYTIC ANEMIA

D. GRAVE'S DISEASE

E. CONTACT DERMATITIS

CORRECT ANS: A. MYASTHENIA GRAVIS
C. HEMOLYTIC ANEMIA

D. GRAVE'S DISEASE



FEEDBACK: TYPE 2 HYPERSENSITIVITY TARGETS SPECIFIC CELLS USING IGG OR IGM
ANTOBODIES




SELECT ALL THAT APPLY:



WHICH ARE CLINICAL MANIFESTATIONS OF HIV?

A. DECREASED CD4 COUNT